Abstract:Objective To investigate the relationship between CD56+ derived IFN-γ expression and the prognosis in patients with cervical cancer.Methods The enrolled participants were 121 patients with cervicitis,cervical precancerous lesions or cervical cancer confirmed by colposcopy biopsy or gynecological surgery in Tangshan Workers' Hospital from February 2008 to November 2011,including 25 with chronic cervicitis (control group),l 1 with cervical intraepithelial neoplasia (CIN) grade Ⅰ (CIN Ⅰ group),45 with CIN grade Ⅱ/Ⅲ (CIN Ⅱ/Ⅲ group),and 40 with squamous carcinoma of the cervix (SCC) (SCC group).We used double-immunofluorescent staining to quantify CD56+ (NK cell specific marker) and CD56+ IFN-γ+ cells in the cervical tissues.The prevalence of HPV16 infection,HPV18 infection and infection with other 12 high-risk types of HPV in the cervical tissues were detected pathologically.Expression of IFN-γ mRNA in the above cervical tissues was measured by qRT-PCR.The SCC group was divided into high-level expression and low-level expression based on the mean value of percentage of CD56+ IFN-γ + cells in the SCC group.All the patients in the SCC group were followed up.Univariate analysis of the survival rate was based on the Kaplan-Meier survival curve,and Log-rank test was used to compare the survival distributions.Multivariate analysis of the survival rate was performed by using the Cox's proportional hazards models.Results The percentage of CD56+ cells and CD56+ IFN-γ + cells differed significantly among the 4 groups (P ＜ 0.05).Compared with the control group,the percentage of CD56+ cells in cervical tissues of CIN Ⅰ group was significantly increased (P ＜ 0.05).Compared with the control and CIN Ⅰ group,the percentage of CD56+ cells increased while that of CD56+ IFN-γ+ cells decreased significantly in cervical tissues of CIN Ⅱ/Ⅲ and SCC group (P ＜ 0.05).Compared with CIN Ⅱ/Ⅲ group,both the percentages of CD56+ cells and CD56+IFN-γ + cells decreased significantly in the cervical tissues of SCC group (P ＜ 0.05).The prevalence of HPV16 infection in the cervical tissues differed obviously among the 4 groups (P ＜ 0.05),but that of HPV18 infection and other 12 high-risk types of HPV infection did not (P ＞ 0.05).Lower expression of IFN-γ mRNA was found in those with HPV16 infection than those without in the control group (P ＜ 0.05).The expression of IFN-γ mRNA was not associated with HPV16 infection in patients in the CIN Ⅰ group (P ＞0.05).Higher expression of IFN-γ mRNA was found in those with HPV16 infection than those without in both the CIN Ⅱ/Ⅲ group and SCC group (P ＜ 0.05).Clinical parameters of lymph node metastasis and FIGO staging were associated with the CD56+IFN-γ+ expression in SCC group (P ＜ 0.05).During the follow-up period,11 (27.5％) of the 40 SCC cases died,the other 29 (72.5％) survived.Patients in high-level expression of CD56+ IFN-γ+ had higher survival rate than those in the low-level expression of CD56+ IFN-γ+ (92.86％ vs.61.54％,x2 =4.405,P =0.036).The Cox regressron analysis showed that,expression of CD56+IFN-γ+ was associated with the prognosis of patients in SCC group [HR =2.592,95％ CI (1.171,4.013),P ＜ 0.05].Conclusion The expression of CD56+ cells significantly increase with the progression of cervical lesions,but the expression of CD56+ IFN-γ+ significantly decline,which may be associated with the prognosis in SCC patients.

Expression and Clinicopathological Significance of Foxp3 and VISTA in Cervical Cancer.

VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer

Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma

The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer

Expression of Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in Cervical Squamous Cell Carcinoma and Its Clinical Significance

Expression and clinical significance of Foxp3 in breast carcinoma tissues

VISTA is Associated with Immune Infiltration and Predicts Favorable Prognosis in TNBC

Expressions of Immune Negative Regulator FoxP3+Treg and PD-L1 Protein in the Immune Microenvironment of Cervical Lesion.

Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer

Expression and clinical significance of VISTA and PD-L1 in adrenocortical carcinoma.

Expression and clinical significance of VISTA, B7-H3, and PD-L1 in glioma

Correlation of expression of IDO and FoxP3 with progression and prognosis of cervical cancer

Positive TIGIT and VISTA Expression Predict Worse Prognosis in Cervical Cancer Patients Treated with (Chemo)radiotherapy.

The expression and prognostic value of Foxp3 in epithelial ovarian cancer

Identification of Potential Prognostic Biomarkers in Vulval Squamous Cell Carcinoma Based on Human Papillomavirus Infection Status-Analysis of GSE183454

VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

[Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis].

VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma

The investigation of regulatory role of immune factors FoxP3,CCL22 and CCR4 in the mi-croenvironment of cervical cancer

Relationship between CD56+-derived IFN-γ Expression and the Prognosis in Cervical Cancer

High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Pathological Features in Patients with Pancreatic Ductal Adenocarcinoma